Diabetes Technology

Latest News

Insulin Pump Associated With Decreased Incidence of Diabetic Ketoacidosis in Youth With Type 1 Diabetes

By

Jessica Nye, PhD

Investigators assessed the prevalence of diabetic complications among youth with type 1 diabetes with or without use of insulin pumps.

Hybrid Closed-Loop Therapy Beneficial for Children With T1D

For children and adolescents with type 1 diabetes, hybrid closed-loop (HCL) therapy improves glycemic control and quality of life.

CGM and CSII: More Effective Blood Glucose Control Than SMBG or MDI in T1D

By

Jessica Nye, PhD

This systematic review and meta-analysis included 14 studies comparing CSII with MDI (8 studies) and CGM with SMBG (6 studies) in type 1 diabetes.

Lyumjev U-100 Approved for Use in Insulin Pumps

By

Brian Park, PharmD

The expanded approval was based on data from the phase 3 PRONTO-PUMP-2 trial which evaluated Lyumjev vs Humalog for use in insulin pump therapy in 432 adults with type 1 diabetes.

Some Remote Digital Monitoring Modalities Perceived as Intrusive by Patients With Diabetes

By

Brandon May

Remote digital monitoring is relatively new in diabetes care. It can be either complimentary to care or intrusive. In this study, researchers focus on concerns patients have from privacy to wearability.

Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

By

Amit Akirov, MD

Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.

Continuous Glucose Monitoring Aids Glycemic Control in Young Adults With Diabetes

Continuous glucose monitoring improves glycemic control in adolescents and young adults with T1D and is beneficial for hypoglycemia in older adults with T1D.

FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes

By

Diana Ernst, RPh

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.

Use of CGM at Diabetes Camps May Reduce Hypoglycemia in Campers

By

Rachael Beairsto

Use of continuous glucose monitoring significantly decreases rates of hypoglycemia among children and adolescents who attend diabetes camps.

Using Smartphone Apps for Glycemic Control in Diabetes: What Improvements Are Still Needed?

By

Madeline Morr

Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.

Implementing CGM for Hospitalized Patients With COVID-19 and Diabetes: Insights From One Medical Center

By

Rachael Beairsto

In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.